Fundraising Fox
Brij Medical
Marietta, US · Founded 2021 · Delaware corporation
Find your way into Brij Medical
Sign up to see every warm intro you have to Brij Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brij Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Brij Medical makes BRIJ-SEAL, a single-use sterile hypoallergenic wound sealant that forms a 14-day bacterial barrier over post-operative incisions, and Brijjit Force Modulating Tissue Bridges, non-invasive skin closure devices that offload incisional tension. The products are used by orthopedic, plastic, and podiatric surgeons for surgical incision management and improved wound healing.
Founders & leadership
RK
Robert KukuljanExecutive
TG
Timothy GleesonCEO and President
FE
Felmont Eaves, III, M.D.Named on SEC filing
JH
Johanna HafnerNamed on SEC filing
AS
Alistair SimpsonNamed on SEC filing
Board
JG
John GrottlingChairman of the Board
JH
James HinrichsBoard director
RZ
Robert ZollarsBoard director
Reported raises · per SEC filings
Form D private placements$16.7M disclosed across 5 of 6 rounds · 2021–2026
▶$5MraisedOct 2026 · 83 investors · Other Health CareRule 506(b)
▶$5MraisedOct 2026 · 83 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy GleesonExecutive Officer, Director
- John GrottlingDirector
- Felmont Eaves, III, M.D.Executive Officer, Director
- Robert KukuljanExecutive Officer
- James HinrichsDirector
- Robert ZollarsDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Oct 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.2MraisedFeb 2026 · 17 investors · Other Health CareRule 506(b)
▶$1.2MraisedFeb 2026 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John GrottlingDirector
- Robert KukuljanExecutive Officer
- Timothy GleesonDirector, Executive Officer
- James HinrichsDirector
- Felmont Eaves, III, M.D.Director, Executive Officer
- Robert ZollarsDirector
- Offering amount
- $6.4M
- Amount sold
- $1.2M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5.6MraisedFeb 2024 · 77 investors · Other Health CareRule 506(b)
▶$5.6MraisedFeb 2024 · 77 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David GrantExecutive Officer
- Felmont Eaves, III, M.D.Director, Executive Officer
- Timothy GleesonDirector, Executive Officer
- John GrottlingDirector
- Robert KukuljanExecutive Officer
- Offering amount
- $5.7M
- Amount sold
- $5.6M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1MofferedAug 2023 · Other Health CareRule 506(b)
▶$1MofferedAug 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert KukuljanExecutive Officer
- Felmont Eaves, III, MDExecutive Officer, Director
- Alistair SimpsonExecutive Officer, Director
- Johnna HafnerExecutive Officer
- Offering amount
- $1M
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$200KraisedSep 2022 · 3 investors · Other Health CareRule 506(c)
▶$200KraisedSep 2022 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- FELMONT F. EAVES, III, MDExecutive Officer, Director
- JOHNNA HAFNERExecutive Officer
- ROBERT A. KUKULJANExecutive Officer
- ALISTAIR SIMPSONExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $200K
- Minimum investment
- $50K
- Proceeds to insiders
- $300K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
▶$4.8MraisedJul 2021 · 43 investors · Other Health CareRule 506(c)
▶$4.8MraisedJul 2021 · 43 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Johanna HafnerExecutive Officer
- Alistair SimpsonExecutive Officer, Director
- Robert A. KukuljanExecutive Officer
- Felmont F. Eaves, III, M.D.Executive Officer, Director
- Offering amount
- $10.1M
- Amount sold
- $4.8M
- Minimum investment
- $25.4K
- Proceeds to insiders
- $700K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
BDBD is a global medical technology company developing devices, systems, and solutions for medication administration, diagnostics, connected care, biopharmaceutical manufacturing, and interventional procedures. The company serves healthcare providers, laboratories, and biopharmaceutical manufacturers across diagnostics, drug delivery, surgical care, and patient monitoring.
Companies working in the same space as Brij Medical.
Frequently asked questions
- What does Brij Medical do?
- Brij Medical makes BRIJ-SEAL, a single-use sterile hypoallergenic wound sealant that forms a 14-day bacterial barrier over post-operative incisions, and Brijjit Force Modulating Tissue Bridges, non-invasive skin closure devices that offload incisional tension. The products are used by orthopedic, plastic, and podiatric surgeons for surgical incision management and improved wound healing.
- How much funding has Brij Medical raised?
- Brij Medical has disclosed $16.7M raised across 5 of its 6 known rounds.
- Where is Brij Medical headquartered?
- Brij Medical is headquartered in Marietta, US.